| 1.4 |
4.3 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 1.0 |
4.9 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.9 |
2.6 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.9 |
5.2 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.9 |
2.6 |
GO:0097401 |
synaptic vesicle lumen acidification(GO:0097401) |
| 0.8 |
3.9 |
GO:1902856 |
negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.8 |
3.1 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.8 |
2.3 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 0.7 |
3.4 |
GO:0002024 |
diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
| 0.7 |
3.4 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.6 |
1.9 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 0.6 |
4.4 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.6 |
1.8 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.6 |
1.8 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 0.6 |
2.3 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.6 |
2.3 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 0.6 |
1.7 |
GO:0061144 |
alveolar secondary septum development(GO:0061144) |
| 0.5 |
1.6 |
GO:0045110 |
intermediate filament bundle assembly(GO:0045110) |
| 0.5 |
1.5 |
GO:0018103 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.5 |
3.1 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.5 |
1.0 |
GO:0046101 |
hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 0.5 |
2.0 |
GO:2000546 |
positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 0.5 |
1.5 |
GO:1901731 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) positive regulation of platelet aggregation(GO:1901731) |
| 0.5 |
2.0 |
GO:2000705 |
regulation of dense core granule biogenesis(GO:2000705) |
| 0.5 |
3.4 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 0.5 |
1.4 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.5 |
1.9 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.5 |
2.3 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.5 |
1.4 |
GO:0032792 |
negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.5 |
0.9 |
GO:0070344 |
fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) |
| 0.4 |
3.1 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.4 |
3.5 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.4 |
1.7 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.4 |
0.4 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.4 |
0.4 |
GO:0010751 |
negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.4 |
1.3 |
GO:1902174 |
positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.4 |
0.8 |
GO:0051582 |
positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.4 |
5.7 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.4 |
6.1 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.4 |
1.2 |
GO:1903334 |
positive regulation of protein folding(GO:1903334) |
| 0.4 |
0.8 |
GO:1901204 |
regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) |
| 0.4 |
1.5 |
GO:1902512 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
| 0.4 |
1.9 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.4 |
1.1 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.4 |
1.9 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.4 |
1.1 |
GO:0003289 |
atrial septum primum morphogenesis(GO:0003289) |
| 0.4 |
1.5 |
GO:0035878 |
nail development(GO:0035878) |
| 0.4 |
1.1 |
GO:0019401 |
alditol biosynthetic process(GO:0019401) |
| 0.4 |
1.5 |
GO:0010808 |
positive regulation of synaptic vesicle priming(GO:0010808) |
| 0.4 |
1.4 |
GO:0036216 |
response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.4 |
2.1 |
GO:0060022 |
hard palate development(GO:0060022) |
| 0.4 |
0.4 |
GO:0048505 |
regulation of timing of cell differentiation(GO:0048505) |
| 0.4 |
1.1 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.4 |
0.4 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
| 0.3 |
0.3 |
GO:0032510 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.3 |
2.1 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.3 |
3.1 |
GO:0033280 |
response to vitamin D(GO:0033280) |
| 0.3 |
1.0 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) |
| 0.3 |
1.0 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.3 |
1.4 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.3 |
1.0 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 0.3 |
1.0 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.3 |
1.3 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.3 |
0.7 |
GO:0042536 |
negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
| 0.3 |
1.0 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.3 |
1.0 |
GO:0050975 |
sensory perception of touch(GO:0050975) |
| 0.3 |
1.0 |
GO:0046022 |
regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.3 |
1.0 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.3 |
0.3 |
GO:0061511 |
centriole elongation(GO:0061511) |
| 0.3 |
1.6 |
GO:0019249 |
lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
| 0.3 |
1.9 |
GO:0035907 |
dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
| 0.3 |
1.3 |
GO:0051295 |
establishment of meiotic spindle localization(GO:0051295) |
| 0.3 |
1.0 |
GO:0002302 |
CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
| 0.3 |
1.6 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 0.3 |
1.3 |
GO:0035795 |
negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 0.3 |
0.3 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.3 |
0.6 |
GO:0048148 |
behavioral response to cocaine(GO:0048148) |
| 0.3 |
1.3 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.3 |
2.8 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.3 |
0.9 |
GO:0046959 |
habituation(GO:0046959) |
| 0.3 |
0.9 |
GO:1902605 |
heterotrimeric G-protein complex assembly(GO:1902605) |
| 0.3 |
0.9 |
GO:1903587 |
regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
| 0.3 |
1.3 |
GO:0032278 |
positive regulation of gonadotropin secretion(GO:0032278) |
| 0.3 |
1.2 |
GO:0007228 |
positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.3 |
1.5 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.3 |
3.7 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.3 |
0.3 |
GO:0030046 |
parallel actin filament bundle assembly(GO:0030046) |
| 0.3 |
0.3 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.3 |
1.5 |
GO:0010990 |
regulation of SMAD protein complex assembly(GO:0010990) |
| 0.3 |
1.5 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.3 |
1.5 |
GO:0048133 |
germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.3 |
1.2 |
GO:0031509 |
telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 0.3 |
0.9 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.3 |
2.6 |
GO:0010764 |
negative regulation of fibroblast migration(GO:0010764) |
| 0.3 |
2.9 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.3 |
3.4 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.3 |
1.1 |
GO:0061526 |
acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
| 0.3 |
0.8 |
GO:0006065 |
UDP-glucuronate biosynthetic process(GO:0006065) |
| 0.3 |
1.1 |
GO:0072369 |
regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.3 |
0.8 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.3 |
2.5 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.3 |
1.4 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.3 |
2.7 |
GO:0009186 |
deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
| 0.3 |
0.3 |
GO:1901536 |
regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
| 0.3 |
0.8 |
GO:0060129 |
thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
| 0.3 |
1.3 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.3 |
0.5 |
GO:0010958 |
regulation of amino acid import(GO:0010958) regulation of L-arginine import(GO:0010963) |
| 0.3 |
1.9 |
GO:0090170 |
regulation of Golgi inheritance(GO:0090170) |
| 0.3 |
1.1 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.3 |
0.3 |
GO:0090135 |
actin filament branching(GO:0090135) |
| 0.3 |
0.5 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.3 |
1.6 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.3 |
1.0 |
GO:0070885 |
negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.3 |
1.0 |
GO:0051708 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) cytosol to ER transport(GO:0046967) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.3 |
1.8 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 0.3 |
0.5 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.3 |
0.5 |
GO:0006059 |
hexitol metabolic process(GO:0006059) |
| 0.3 |
0.8 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.2 |
0.7 |
GO:0060334 |
regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.2 |
1.2 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.2 |
4.2 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.2 |
1.2 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.2 |
0.5 |
GO:0010040 |
response to iron(II) ion(GO:0010040) |
| 0.2 |
0.5 |
GO:0035519 |
protein K29-linked ubiquitination(GO:0035519) |
| 0.2 |
0.7 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.2 |
0.7 |
GO:1902277 |
negative regulation of pancreatic amylase secretion(GO:1902277) |
| 0.2 |
2.6 |
GO:0021785 |
branchiomotor neuron axon guidance(GO:0021785) |
| 0.2 |
0.5 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.2 |
0.5 |
GO:1900041 |
negative regulation of interleukin-2 secretion(GO:1900041) |
| 0.2 |
0.9 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.2 |
0.5 |
GO:1903898 |
negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 0.2 |
0.2 |
GO:0061245 |
establishment or maintenance of apical/basal cell polarity(GO:0035088) establishment or maintenance of bipolar cell polarity(GO:0061245) |
| 0.2 |
1.2 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.2 |
0.5 |
GO:0097278 |
complement-dependent cytotoxicity(GO:0097278) |
| 0.2 |
0.9 |
GO:0003430 |
growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.2 |
4.6 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.2 |
0.2 |
GO:0032472 |
Golgi calcium ion transport(GO:0032472) |
| 0.2 |
0.7 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.2 |
0.7 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.2 |
0.7 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.2 |
1.4 |
GO:0036258 |
multivesicular body assembly(GO:0036258) |
| 0.2 |
0.7 |
GO:0001827 |
inner cell mass cell fate commitment(GO:0001827) |
| 0.2 |
3.6 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
| 0.2 |
1.1 |
GO:1902047 |
polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
| 0.2 |
0.9 |
GO:0051866 |
general adaptation syndrome(GO:0051866) |
| 0.2 |
0.7 |
GO:0097309 |
cap1 mRNA methylation(GO:0097309) |
| 0.2 |
0.4 |
GO:0001956 |
positive regulation of neurotransmitter secretion(GO:0001956) positive regulation of neurotransmitter transport(GO:0051590) |
| 0.2 |
0.2 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.2 |
0.2 |
GO:0046958 |
nonassociative learning(GO:0046958) |
| 0.2 |
0.7 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.2 |
0.2 |
GO:0060527 |
prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
| 0.2 |
0.2 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.2 |
3.3 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.2 |
2.2 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.2 |
0.7 |
GO:1904058 |
positive regulation of sensory perception of pain(GO:1904058) |
| 0.2 |
3.5 |
GO:0045019 |
negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
| 0.2 |
1.5 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.2 |
1.1 |
GO:2000587 |
regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.2 |
0.2 |
GO:1990379 |
lipid transport across blood brain barrier(GO:1990379) |
| 0.2 |
0.6 |
GO:0043323 |
positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.2 |
2.1 |
GO:1900025 |
negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
| 0.2 |
2.4 |
GO:1901250 |
regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
| 0.2 |
0.6 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) regulation of opioid receptor signaling pathway(GO:2000474) |
| 0.2 |
0.2 |
GO:0003219 |
cardiac right ventricle formation(GO:0003219) |
| 0.2 |
2.8 |
GO:0016188 |
synaptic vesicle maturation(GO:0016188) |
| 0.2 |
1.1 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.2 |
0.2 |
GO:0033046 |
negative regulation of sister chromatid segregation(GO:0033046) negative regulation of mitotic sister chromatid segregation(GO:0033048) |
| 0.2 |
0.8 |
GO:0044268 |
multicellular organismal protein metabolic process(GO:0044268) |
| 0.2 |
0.6 |
GO:0014042 |
positive regulation of neuron maturation(GO:0014042) |
| 0.2 |
1.1 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 0.2 |
0.2 |
GO:0042320 |
regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) circadian sleep/wake cycle, REM sleep(GO:0042747) |
| 0.2 |
1.3 |
GO:0086103 |
G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
| 0.2 |
0.2 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.2 |
0.8 |
GO:1902715 |
positive regulation of interferon-gamma secretion(GO:1902715) |
| 0.2 |
0.6 |
GO:1901675 |
response to methylglyoxal(GO:0051595) negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.2 |
1.5 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
| 0.2 |
0.2 |
GO:0090091 |
positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.2 |
0.6 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 0.2 |
0.8 |
GO:0032382 |
positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) positive regulation of cholesterol import(GO:1904109) positive regulation of sterol import(GO:2000911) |
| 0.2 |
0.6 |
GO:2000813 |
negative regulation of barbed-end actin filament capping(GO:2000813) |
| 0.2 |
0.4 |
GO:0035774 |
positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
| 0.2 |
0.2 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.2 |
0.6 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
| 0.2 |
1.2 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.2 |
0.6 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.2 |
1.4 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.2 |
0.4 |
GO:0006278 |
RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
| 0.2 |
1.0 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.2 |
0.6 |
GO:2000054 |
negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
| 0.2 |
0.8 |
GO:0090238 |
positive regulation of arachidonic acid secretion(GO:0090238) |
| 0.2 |
0.8 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.2 |
1.0 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.2 |
0.6 |
GO:1902219 |
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.2 |
1.0 |
GO:0060398 |
regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 0.2 |
1.0 |
GO:0071985 |
multivesicular body sorting pathway(GO:0071985) |
| 0.2 |
0.2 |
GO:0097211 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.2 |
0.2 |
GO:0034447 |
very-low-density lipoprotein particle clearance(GO:0034447) |
| 0.2 |
0.4 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.2 |
0.8 |
GO:0046294 |
formaldehyde catabolic process(GO:0046294) |
| 0.2 |
0.4 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.2 |
0.6 |
GO:0070844 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.2 |
0.8 |
GO:0072513 |
positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.2 |
0.8 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.2 |
1.6 |
GO:1903298 |
regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
| 0.2 |
2.0 |
GO:0014824 |
artery smooth muscle contraction(GO:0014824) |
| 0.2 |
0.8 |
GO:2001271 |
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.2 |
0.8 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.2 |
1.0 |
GO:1900147 |
Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 0.2 |
1.7 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.2 |
0.2 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 0.2 |
1.9 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.2 |
0.6 |
GO:0021564 |
glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 0.2 |
0.9 |
GO:0038032 |
termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 0.2 |
0.8 |
GO:0006207 |
'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.2 |
0.6 |
GO:0001193 |
maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
| 0.2 |
0.6 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.2 |
0.4 |
GO:0032513 |
negative regulation of protein phosphatase type 2B activity(GO:0032513) |
| 0.2 |
1.1 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.2 |
0.5 |
GO:0018008 |
N-terminal peptidyl-glycine N-myristoylation(GO:0018008) peptidyl-glycine modification(GO:0018201) |
| 0.2 |
0.7 |
GO:0051036 |
regulation of endosome size(GO:0051036) |
| 0.2 |
0.4 |
GO:0060744 |
thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.2 |
0.5 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 0.2 |
0.9 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.2 |
0.2 |
GO:0010640 |
regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
| 0.2 |
1.6 |
GO:1904587 |
glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
| 0.2 |
0.9 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 0.2 |
0.4 |
GO:0072176 |
nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
| 0.2 |
0.9 |
GO:1900040 |
regulation of interleukin-2 secretion(GO:1900040) |
| 0.2 |
0.2 |
GO:2001223 |
negative regulation of neuron migration(GO:2001223) |
| 0.2 |
0.4 |
GO:0098828 |
modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.2 |
0.5 |
GO:0070346 |
positive regulation of fat cell proliferation(GO:0070346) |
| 0.2 |
0.4 |
GO:0032570 |
response to progesterone(GO:0032570) |
| 0.2 |
0.5 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 0.2 |
1.6 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.2 |
0.2 |
GO:0032701 |
negative regulation of interleukin-18 production(GO:0032701) |
| 0.2 |
0.7 |
GO:0065001 |
negative regulation of histone H3-K36 methylation(GO:0000415) specification of axis polarity(GO:0065001) |
| 0.2 |
0.2 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.2 |
0.7 |
GO:0010288 |
response to lead ion(GO:0010288) |
| 0.2 |
0.5 |
GO:0035574 |
histone H4-K20 demethylation(GO:0035574) |
| 0.2 |
0.7 |
GO:0042473 |
outer ear morphogenesis(GO:0042473) |
| 0.2 |
0.5 |
GO:0051491 |
positive regulation of filopodium assembly(GO:0051491) |
| 0.2 |
0.5 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.2 |
1.4 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.2 |
0.8 |
GO:0033136 |
serine phosphorylation of STAT3 protein(GO:0033136) serine phosphorylation of STAT protein(GO:0042501) |
| 0.2 |
0.8 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.2 |
1.2 |
GO:0046541 |
saliva secretion(GO:0046541) |
| 0.2 |
1.7 |
GO:0060013 |
righting reflex(GO:0060013) |
| 0.2 |
1.5 |
GO:0060028 |
convergent extension involved in axis elongation(GO:0060028) |
| 0.2 |
0.7 |
GO:1901524 |
regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) negative regulation of mitophagy(GO:1903147) |
| 0.2 |
0.8 |
GO:0090666 |
scaRNA localization to Cajal body(GO:0090666) |
| 0.2 |
0.5 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.2 |
0.3 |
GO:0021577 |
hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 0.2 |
0.5 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.2 |
0.5 |
GO:0051305 |
chromosome movement towards spindle pole(GO:0051305) |
| 0.2 |
0.3 |
GO:0032714 |
negative regulation of interleukin-13 production(GO:0032696) negative regulation of interleukin-5 production(GO:0032714) |
| 0.2 |
0.7 |
GO:1902302 |
regulation of potassium ion export(GO:1902302) |
| 0.2 |
0.2 |
GO:1904192 |
cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
| 0.2 |
1.3 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.2 |
0.5 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.2 |
0.2 |
GO:2000642 |
negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.2 |
0.2 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.2 |
2.3 |
GO:0006085 |
acetyl-CoA biosynthetic process(GO:0006085) |
| 0.2 |
0.2 |
GO:0007403 |
glial cell fate determination(GO:0007403) |
| 0.2 |
0.2 |
GO:0060489 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 0.2 |
0.5 |
GO:0045014 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.2 |
1.4 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.2 |
3.2 |
GO:0050650 |
chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.2 |
0.3 |
GO:0032025 |
response to cobalt ion(GO:0032025) |
| 0.2 |
1.1 |
GO:0006817 |
phosphate ion transport(GO:0006817) |
| 0.2 |
0.6 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.2 |
0.8 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.2 |
0.2 |
GO:1901841 |
regulation of high voltage-gated calcium channel activity(GO:1901841) |
| 0.2 |
1.6 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.2 |
0.5 |
GO:0048537 |
mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
| 0.2 |
0.2 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.2 |
0.6 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.2 |
0.3 |
GO:0090261 |
positive regulation of inclusion body assembly(GO:0090261) |
| 0.2 |
0.9 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.2 |
1.1 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.2 |
0.2 |
GO:0010749 |
regulation of nitric oxide mediated signal transduction(GO:0010749) |
| 0.2 |
0.8 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
| 0.2 |
0.8 |
GO:0072429 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.2 |
0.8 |
GO:0000480 |
endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.2 |
1.1 |
GO:0051561 |
positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
| 0.2 |
0.3 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.2 |
0.5 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.1 |
0.4 |
GO:0070428 |
regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
| 0.1 |
1.3 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.1 |
0.6 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.1 |
0.3 |
GO:0001306 |
age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
| 0.1 |
2.7 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.1 |
1.6 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.1 |
0.6 |
GO:0061055 |
myotome development(GO:0061055) |
| 0.1 |
2.2 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 0.1 |
0.6 |
GO:0032509 |
endosome transport via multivesicular body sorting pathway(GO:0032509) |
| 0.1 |
0.3 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.1 |
0.7 |
GO:0021993 |
initiation of neural tube closure(GO:0021993) |
| 0.1 |
0.6 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.1 |
1.2 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.1 |
0.6 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.1 |
1.3 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.1 |
0.1 |
GO:0051974 |
negative regulation of telomerase activity(GO:0051974) |
| 0.1 |
0.1 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.1 |
0.1 |
GO:0061188 |
regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.1 |
0.3 |
GO:0031047 |
gene silencing by RNA(GO:0031047) |
| 0.1 |
0.4 |
GO:0048211 |
Golgi vesicle docking(GO:0048211) |
| 0.1 |
0.3 |
GO:0007341 |
penetration of zona pellucida(GO:0007341) |
| 0.1 |
2.0 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.1 |
0.3 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.1 |
0.3 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.1 |
2.8 |
GO:0002076 |
osteoblast development(GO:0002076) |
| 0.1 |
0.4 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |
| 0.1 |
3.5 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.1 |
2.4 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.1 |
2.0 |
GO:0006337 |
nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
| 0.1 |
0.3 |
GO:0018171 |
peptidyl-cysteine oxidation(GO:0018171) |
| 0.1 |
0.6 |
GO:1903624 |
regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
| 0.1 |
0.1 |
GO:2000138 |
positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
| 0.1 |
0.3 |
GO:0060279 |
positive regulation of ovulation(GO:0060279) |
| 0.1 |
0.4 |
GO:0048698 |
negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.1 |
1.1 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 0.1 |
0.1 |
GO:0016264 |
gap junction assembly(GO:0016264) |
| 0.1 |
1.1 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.1 |
1.0 |
GO:0031547 |
brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.1 |
1.0 |
GO:0051792 |
medium-chain fatty acid biosynthetic process(GO:0051792) |
| 0.1 |
0.1 |
GO:0061535 |
glutamate secretion, neurotransmission(GO:0061535) |
| 0.1 |
1.4 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.1 |
0.3 |
GO:0019405 |
alditol catabolic process(GO:0019405) |
| 0.1 |
0.5 |
GO:0006407 |
rRNA export from nucleus(GO:0006407) |
| 0.1 |
0.4 |
GO:0034436 |
glycoprotein transport(GO:0034436) |
| 0.1 |
0.1 |
GO:0046835 |
carbohydrate phosphorylation(GO:0046835) |
| 0.1 |
0.8 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.1 |
0.5 |
GO:0010387 |
COP9 signalosome assembly(GO:0010387) |
| 0.1 |
0.8 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.1 |
0.4 |
GO:0071929 |
alpha-tubulin acetylation(GO:0071929) |
| 0.1 |
0.7 |
GO:0031340 |
positive regulation of vesicle fusion(GO:0031340) |
| 0.1 |
1.2 |
GO:0048477 |
oogenesis(GO:0048477) |
| 0.1 |
0.3 |
GO:0032055 |
negative regulation of translation in response to stress(GO:0032055) |
| 0.1 |
0.4 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.1 |
0.4 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.1 |
0.5 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
| 0.1 |
0.3 |
GO:0042524 |
negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
| 0.1 |
2.5 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.1 |
0.3 |
GO:0042726 |
flavin-containing compound metabolic process(GO:0042726) |
| 0.1 |
0.1 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.1 |
0.3 |
GO:0045820 |
negative regulation of glycolytic process(GO:0045820) |
| 0.1 |
2.2 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.1 |
0.9 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.1 |
0.7 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.1 |
0.1 |
GO:0060696 |
regulation of phospholipid catabolic process(GO:0060696) |
| 0.1 |
0.1 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.1 |
0.9 |
GO:0035902 |
response to immobilization stress(GO:0035902) |
| 0.1 |
2.4 |
GO:0046931 |
pore complex assembly(GO:0046931) |
| 0.1 |
0.3 |
GO:0032804 |
negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) negative regulation of receptor catabolic process(GO:2000645) |
| 0.1 |
0.1 |
GO:2000767 |
positive regulation of cytoplasmic translation(GO:2000767) |
| 0.1 |
0.4 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.1 |
0.9 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.1 |
1.2 |
GO:0046599 |
regulation of centriole replication(GO:0046599) |
| 0.1 |
0.4 |
GO:0000710 |
meiotic mismatch repair(GO:0000710) |
| 0.1 |
0.5 |
GO:0071493 |
cellular response to UV-B(GO:0071493) |
| 0.1 |
0.3 |
GO:1902237 |
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.1 |
0.4 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
| 0.1 |
0.8 |
GO:0090383 |
phagosome acidification(GO:0090383) |
| 0.1 |
1.2 |
GO:0006084 |
acetyl-CoA metabolic process(GO:0006084) |
| 0.1 |
0.1 |
GO:2000628 |
regulation of miRNA metabolic process(GO:2000628) |
| 0.1 |
0.6 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.1 |
0.3 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.1 |
0.3 |
GO:0061418 |
regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
| 0.1 |
0.4 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.1 |
0.4 |
GO:2001137 |
positive regulation of endocytic recycling(GO:2001137) |
| 0.1 |
0.6 |
GO:0010961 |
cellular magnesium ion homeostasis(GO:0010961) |
| 0.1 |
0.2 |
GO:0018364 |
peptidyl-glutamine methylation(GO:0018364) |
| 0.1 |
0.5 |
GO:2000018 |
regulation of male gonad development(GO:2000018) positive regulation of male gonad development(GO:2000020) |
| 0.1 |
1.1 |
GO:1902913 |
positive regulation of melanocyte differentiation(GO:0045636) positive regulation of developmental pigmentation(GO:0048087) positive regulation of pigment cell differentiation(GO:0050942) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
| 0.1 |
0.4 |
GO:0019676 |
ammonia assimilation cycle(GO:0019676) |
| 0.1 |
1.2 |
GO:0009209 |
pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) |
| 0.1 |
0.4 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.1 |
2.4 |
GO:0045214 |
sarcomere organization(GO:0045214) |
| 0.1 |
0.1 |
GO:1900369 |
negative regulation of RNA interference(GO:1900369) |
| 0.1 |
0.1 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.1 |
0.1 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) |
| 0.1 |
0.4 |
GO:0006999 |
nuclear pore organization(GO:0006999) |
| 0.1 |
0.5 |
GO:0061002 |
negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.1 |
0.5 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.1 |
0.2 |
GO:0070309 |
lens fiber cell morphogenesis(GO:0070309) |
| 0.1 |
1.3 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 |
2.0 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 |
0.1 |
GO:0010884 |
positive regulation of lipid storage(GO:0010884) |
| 0.1 |
0.8 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.1 |
0.8 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.1 |
1.7 |
GO:0038063 |
collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.1 |
4.9 |
GO:0006506 |
GPI anchor biosynthetic process(GO:0006506) |
| 0.1 |
0.6 |
GO:0009052 |
pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.1 |
2.6 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.1 |
0.5 |
GO:1990743 |
protein sialylation(GO:1990743) |
| 0.1 |
0.6 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
| 0.1 |
0.6 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.1 |
0.6 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.1 |
2.1 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.1 |
1.0 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.1 |
0.3 |
GO:0070172 |
positive regulation of tooth mineralization(GO:0070172) |
| 0.1 |
0.2 |
GO:0030240 |
skeletal muscle thin filament assembly(GO:0030240) |
| 0.1 |
0.8 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.1 |
0.5 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.1 |
0.1 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.1 |
0.8 |
GO:0043922 |
negative regulation by host of viral transcription(GO:0043922) |
| 0.1 |
2.0 |
GO:0033137 |
negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
| 0.1 |
0.6 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.1 |
0.3 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.1 |
0.3 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.1 |
0.3 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.1 |
1.2 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.1 |
0.3 |
GO:0010745 |
negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.1 |
0.3 |
GO:0048261 |
negative regulation of receptor-mediated endocytosis(GO:0048261) |
| 0.1 |
0.2 |
GO:0039703 |
viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.1 |
3.4 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.1 |
1.4 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.1 |
0.1 |
GO:0003431 |
growth plate cartilage chondrocyte development(GO:0003431) |
| 0.1 |
0.3 |
GO:0021592 |
fourth ventricle development(GO:0021592) |
| 0.1 |
0.3 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.1 |
0.5 |
GO:0072610 |
interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.1 |
0.4 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.1 |
0.3 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.1 |
0.1 |
GO:0021678 |
third ventricle development(GO:0021678) |
| 0.1 |
0.3 |
GO:0002692 |
negative regulation of cellular extravasation(GO:0002692) negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.1 |
0.3 |
GO:0014848 |
urinary tract smooth muscle contraction(GO:0014848) |
| 0.1 |
0.2 |
GO:0014046 |
dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.1 |
1.3 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.1 |
0.3 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.1 |
0.3 |
GO:0060997 |
dendritic spine morphogenesis(GO:0060997) |
| 0.1 |
0.8 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.1 |
1.4 |
GO:0061462 |
protein localization to lysosome(GO:0061462) |
| 0.1 |
0.8 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.1 |
0.2 |
GO:1903301 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.1 |
0.2 |
GO:2000508 |
regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.1 |
1.9 |
GO:0071357 |
type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 0.1 |
1.5 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.1 |
0.3 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.1 |
2.2 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
| 0.1 |
0.3 |
GO:2001206 |
positive regulation of osteoclast development(GO:2001206) |
| 0.1 |
0.3 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.1 |
0.2 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.1 |
0.4 |
GO:0044330 |
canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) lactic acid secretion(GO:0046722) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.1 |
0.5 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.1 |
0.2 |
GO:1900133 |
renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) renin secretion into blood stream(GO:0002001) regulation of renin secretion into blood stream(GO:1900133) |
| 0.1 |
0.6 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) |
| 0.1 |
1.1 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.1 |
1.1 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.1 |
1.1 |
GO:0090140 |
regulation of mitochondrial fission(GO:0090140) |
| 0.1 |
0.3 |
GO:0000965 |
mitochondrial RNA 3'-end processing(GO:0000965) |
| 0.1 |
0.6 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.1 |
0.3 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.1 |
0.4 |
GO:0033210 |
leptin-mediated signaling pathway(GO:0033210) |
| 0.1 |
0.1 |
GO:1901843 |
positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 0.1 |
0.2 |
GO:0010815 |
bradykinin catabolic process(GO:0010815) |
| 0.1 |
0.7 |
GO:0009120 |
deoxyribonucleoside metabolic process(GO:0009120) |
| 0.1 |
0.7 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.1 |
1.0 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.1 |
0.5 |
GO:0070126 |
mitochondrial translational termination(GO:0070126) |
| 0.1 |
0.2 |
GO:0010986 |
positive regulation of lipoprotein particle clearance(GO:0010986) |
| 0.1 |
0.6 |
GO:1901837 |
negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.1 |
0.1 |
GO:0006448 |
regulation of translational elongation(GO:0006448) |
| 0.1 |
1.5 |
GO:0016082 |
synaptic vesicle priming(GO:0016082) |
| 0.1 |
1.0 |
GO:0060065 |
uterus development(GO:0060065) |
| 0.1 |
0.1 |
GO:0030214 |
hyaluronan catabolic process(GO:0030214) |
| 0.1 |
0.4 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.1 |
0.5 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.1 |
2.1 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.1 |
0.5 |
GO:0030423 |
targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
| 0.1 |
1.2 |
GO:1902751 |
positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.1 |
0.9 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.1 |
0.3 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
| 0.1 |
0.7 |
GO:0072431 |
signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
| 0.1 |
0.2 |
GO:0061622 |
glycolytic process through glucose-1-phosphate(GO:0061622) |
| 0.1 |
0.4 |
GO:0072539 |
T-helper 17 cell differentiation(GO:0072539) |
| 0.1 |
0.2 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 0.1 |
0.6 |
GO:0006361 |
transcription initiation from RNA polymerase I promoter(GO:0006361) |
| 0.1 |
0.9 |
GO:0051016 |
barbed-end actin filament capping(GO:0051016) |
| 0.1 |
0.6 |
GO:0060837 |
blood vessel endothelial cell differentiation(GO:0060837) |
| 0.1 |
0.2 |
GO:0042940 |
D-amino acid transport(GO:0042940) |
| 0.1 |
0.3 |
GO:0021631 |
optic nerve morphogenesis(GO:0021631) |
| 0.1 |
0.2 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 |
0.1 |
GO:0043278 |
response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.1 |
0.7 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.1 |
0.1 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.1 |
0.5 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.1 |
0.3 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.1 |
1.0 |
GO:0090036 |
regulation of protein kinase C signaling(GO:0090036) |
| 0.1 |
0.2 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.1 |
0.2 |
GO:0035928 |
rRNA import into mitochondrion(GO:0035928) rRNA transport(GO:0051029) |
| 0.1 |
0.1 |
GO:0002154 |
thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
| 0.1 |
0.5 |
GO:0042104 |
positive regulation of activated T cell proliferation(GO:0042104) |
| 0.1 |
0.2 |
GO:0043369 |
CD4-positive or CD8-positive, alpha-beta T cell lineage commitment(GO:0043369) |
| 0.1 |
0.3 |
GO:0006363 |
termination of RNA polymerase I transcription(GO:0006363) |
| 0.1 |
0.3 |
GO:0046061 |
dATP catabolic process(GO:0046061) |
| 0.1 |
0.7 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.1 |
0.7 |
GO:0010878 |
cholesterol storage(GO:0010878) |
| 0.1 |
0.7 |
GO:0071257 |
cellular response to electrical stimulus(GO:0071257) |
| 0.1 |
0.1 |
GO:0033122 |
regulation of purine nucleotide catabolic process(GO:0033121) negative regulation of purine nucleotide catabolic process(GO:0033122) |
| 0.1 |
0.3 |
GO:0038027 |
apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
| 0.1 |
0.3 |
GO:1903427 |
negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
| 0.1 |
1.2 |
GO:0043153 |
entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.1 |
0.3 |
GO:1902230 |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
| 0.1 |
0.4 |
GO:0045779 |
negative regulation of bone resorption(GO:0045779) |
| 0.1 |
0.5 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.1 |
0.4 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.1 |
2.8 |
GO:0009214 |
cyclic nucleotide catabolic process(GO:0009214) |
| 0.1 |
0.2 |
GO:0042373 |
vitamin K metabolic process(GO:0042373) |
| 0.1 |
0.1 |
GO:0070858 |
negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.1 |
1.7 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
| 0.1 |
0.3 |
GO:1901096 |
regulation of autophagosome maturation(GO:1901096) |
| 0.1 |
2.2 |
GO:0046513 |
ceramide biosynthetic process(GO:0046513) |
| 0.1 |
0.7 |
GO:0035635 |
entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
| 0.1 |
0.5 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.1 |
0.4 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.1 |
0.1 |
GO:0036015 |
response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 0.1 |
0.3 |
GO:0032693 |
negative regulation of interleukin-10 production(GO:0032693) |
| 0.1 |
0.3 |
GO:0071864 |
positive regulation of cell proliferation in bone marrow(GO:0071864) |
| 0.1 |
0.3 |
GO:0010917 |
negative regulation of mitochondrial membrane potential(GO:0010917) |
| 0.1 |
0.2 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.1 |
0.3 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 0.1 |
0.3 |
GO:0035672 |
oligopeptide transmembrane transport(GO:0035672) |
| 0.1 |
1.6 |
GO:0042059 |
negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.1 |
0.2 |
GO:0035090 |
maintenance of apical/basal cell polarity(GO:0035090) |
| 0.1 |
0.3 |
GO:0015960 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.1 |
0.6 |
GO:0050765 |
negative regulation of phagocytosis(GO:0050765) |
| 0.1 |
0.1 |
GO:2001245 |
regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
| 0.1 |
1.5 |
GO:0098743 |
cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
| 0.1 |
0.6 |
GO:0061029 |
eyelid development in camera-type eye(GO:0061029) |
| 0.1 |
0.2 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.1 |
2.1 |
GO:0006783 |
heme biosynthetic process(GO:0006783) |
| 0.1 |
0.2 |
GO:0006106 |
fumarate metabolic process(GO:0006106) |
| 0.1 |
0.4 |
GO:0015692 |
vanadium ion transport(GO:0015676) lead ion transport(GO:0015692) |
| 0.1 |
0.3 |
GO:0050910 |
detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.1 |
0.1 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.1 |
0.7 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.1 |
0.2 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.1 |
0.2 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 0.1 |
0.3 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.1 |
0.2 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.1 |
0.9 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.1 |
0.2 |
GO:0090365 |
regulation of mRNA modification(GO:0090365) |
| 0.1 |
2.1 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.1 |
0.1 |
GO:2000188 |
regulation of cholesterol homeostasis(GO:2000188) |
| 0.1 |
3.2 |
GO:0009060 |
aerobic respiration(GO:0009060) |
| 0.1 |
0.4 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.1 |
0.2 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.1 |
0.4 |
GO:0006098 |
pentose-phosphate shunt(GO:0006098) |
| 0.1 |
0.2 |
GO:0071880 |
adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 0.1 |
1.2 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 0.1 |
0.3 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.1 |
0.5 |
GO:0060644 |
mammary gland epithelial cell differentiation(GO:0060644) |
| 0.1 |
0.2 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.1 |
0.2 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.1 |
0.1 |
GO:0036228 |
protein targeting to nuclear inner membrane(GO:0036228) |
| 0.1 |
0.1 |
GO:0035087 |
siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.1 |
0.2 |
GO:1903048 |
regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 0.1 |
0.5 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.1 |
1.3 |
GO:0008214 |
protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
| 0.1 |
0.7 |
GO:0005980 |
polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.1 |
0.1 |
GO:0036112 |
medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.1 |
0.1 |
GO:0009220 |
pyrimidine ribonucleotide biosynthetic process(GO:0009220) pyrimidine ribonucleoside biosynthetic process(GO:0046132) |
| 0.1 |
0.1 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.1 |
0.1 |
GO:0006625 |
protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.1 |
0.7 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 0.1 |
1.2 |
GO:0006024 |
glycosaminoglycan biosynthetic process(GO:0006024) |
| 0.1 |
0.4 |
GO:0009133 |
nucleoside diphosphate biosynthetic process(GO:0009133) |
| 0.1 |
0.4 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.1 |
1.1 |
GO:0034643 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.1 |
0.6 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.1 |
0.1 |
GO:0002578 |
negative regulation of antigen processing and presentation(GO:0002578) |
| 0.1 |
1.3 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.1 |
0.6 |
GO:0016242 |
negative regulation of macroautophagy(GO:0016242) |
| 0.1 |
0.1 |
GO:0031990 |
mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.1 |
0.1 |
GO:0021913 |
regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.1 |
0.7 |
GO:0007191 |
adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.1 |
0.5 |
GO:0021830 |
interneuron migration from the subpallium to the cortex(GO:0021830) |
| 0.1 |
0.4 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 0.1 |
0.1 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.1 |
0.6 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.1 |
1.2 |
GO:0044819 |
mitotic G1/S transition checkpoint(GO:0044819) |
| 0.1 |
0.1 |
GO:1901509 |
regulation of endothelial tube morphogenesis(GO:1901509) |
| 0.1 |
0.5 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.1 |
0.5 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.1 |
0.1 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.1 |
1.3 |
GO:0045197 |
establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
| 0.1 |
0.2 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 0.1 |
0.1 |
GO:0071609 |
chemokine (C-C motif) ligand 5 production(GO:0071609) |
| 0.1 |
0.3 |
GO:0046950 |
cellular ketone body metabolic process(GO:0046950) |
| 0.1 |
0.2 |
GO:0000350 |
generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 0.1 |
0.3 |
GO:0071205 |
protein localization to juxtaparanode region of axon(GO:0071205) |
| 0.1 |
0.3 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.1 |
0.3 |
GO:0046015 |
regulation of transcription by glucose(GO:0046015) |
| 0.1 |
1.3 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.1 |
0.5 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.1 |
0.4 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.1 |
0.1 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.1 |
0.1 |
GO:0009838 |
abscission(GO:0009838) |
| 0.1 |
0.5 |
GO:0044068 |
modulation by symbiont of host cellular process(GO:0044068) |
| 0.1 |
0.3 |
GO:0090164 |
asymmetric Golgi ribbon formation(GO:0090164) |
| 0.1 |
0.7 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 |
0.3 |
GO:0072757 |
cellular response to camptothecin(GO:0072757) |
| 0.1 |
0.1 |
GO:0043974 |
histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
| 0.1 |
0.1 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.1 |
0.7 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.1 |
0.2 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.1 |
0.9 |
GO:0035025 |
positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.1 |
0.3 |
GO:0009409 |
response to cold(GO:0009409) |
| 0.1 |
2.9 |
GO:0032543 |
mitochondrial translation(GO:0032543) |
| 0.1 |
0.5 |
GO:0097034 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.1 |
0.1 |
GO:0045410 |
positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
| 0.1 |
0.1 |
GO:0009446 |
putrescine biosynthetic process(GO:0009446) |
| 0.1 |
0.1 |
GO:1903336 |
negative regulation of vacuolar transport(GO:1903336) |
| 0.1 |
0.1 |
GO:0099612 |
protein localization to paranode region of axon(GO:0002175) protein localization to axon(GO:0099612) |
| 0.1 |
0.3 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 0.1 |
0.1 |
GO:0016479 |
negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
| 0.1 |
0.3 |
GO:0007603 |
phototransduction, visible light(GO:0007603) |
| 0.1 |
0.1 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.1 |
0.7 |
GO:2000653 |
regulation of genetic imprinting(GO:2000653) |
| 0.1 |
0.2 |
GO:0044088 |
regulation of vacuole organization(GO:0044088) |
| 0.1 |
1.4 |
GO:0045540 |
regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.1 |
0.2 |
GO:1900027 |
regulation of ruffle assembly(GO:1900027) |
| 0.1 |
0.2 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 |
0.2 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.1 |
0.7 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.1 |
0.6 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.1 |
0.2 |
GO:0031086 |
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.1 |
0.6 |
GO:0061577 |
calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
| 0.1 |
0.1 |
GO:1900368 |
regulation of RNA interference(GO:1900368) |
| 0.1 |
0.8 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.1 |
0.4 |
GO:0008300 |
isoprenoid catabolic process(GO:0008300) |
| 0.1 |
0.3 |
GO:0006071 |
glycerol metabolic process(GO:0006071) |
| 0.1 |
0.1 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.1 |
0.6 |
GO:0033292 |
T-tubule organization(GO:0033292) |
| 0.1 |
0.5 |
GO:0006308 |
DNA catabolic process(GO:0006308) |
| 0.1 |
1.1 |
GO:0006825 |
copper ion transport(GO:0006825) |
| 0.1 |
0.4 |
GO:0097039 |
protein linear polyubiquitination(GO:0097039) |
| 0.1 |
0.4 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) |
| 0.1 |
0.1 |
GO:0001787 |
natural killer cell proliferation(GO:0001787) |
| 0.1 |
0.7 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.1 |
0.2 |
GO:1990173 |
protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
| 0.1 |
1.7 |
GO:0000462 |
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.1 |
0.3 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.1 |
0.1 |
GO:2000172 |
regulation of branching morphogenesis of a nerve(GO:2000172) |
| 0.1 |
0.4 |
GO:0031069 |
hair follicle morphogenesis(GO:0031069) |
| 0.1 |
1.1 |
GO:0021692 |
cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
| 0.1 |
0.5 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.1 |
0.1 |
GO:2000832 |
negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
| 0.1 |
0.1 |
GO:0010867 |
positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.1 |
0.1 |
GO:0000727 |
double-strand break repair via break-induced replication(GO:0000727) |
| 0.1 |
0.7 |
GO:0071428 |
rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
| 0.1 |
0.5 |
GO:0003016 |
respiratory system process(GO:0003016) |
| 0.1 |
0.1 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.1 |
0.3 |
GO:0086026 |
atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
| 0.1 |
0.1 |
GO:0048255 |
mRNA stabilization(GO:0048255) |
| 0.1 |
0.3 |
GO:0002182 |
cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 0.1 |
0.2 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.1 |
0.7 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.1 |
0.5 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.1 |
0.2 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.1 |
0.1 |
GO:1901979 |
regulation of inward rectifier potassium channel activity(GO:1901979) |
| 0.1 |
0.3 |
GO:0046135 |
pyrimidine ribonucleoside catabolic process(GO:0046133) pyrimidine nucleoside catabolic process(GO:0046135) |
| 0.1 |
8.3 |
GO:0042787 |
protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.1 |
0.3 |
GO:0010763 |
positive regulation of fibroblast migration(GO:0010763) |
| 0.1 |
0.1 |
GO:2000467 |
positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.1 |
0.2 |
GO:0045655 |
regulation of monocyte differentiation(GO:0045655) positive regulation of monocyte differentiation(GO:0045657) |
| 0.1 |
0.2 |
GO:0033580 |
protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
| 0.1 |
0.1 |
GO:2000409 |
positive regulation of T cell extravasation(GO:2000409) |
| 0.1 |
0.2 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.1 |
0.2 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 0.1 |
0.1 |
GO:0021965 |
spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.1 |
0.1 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.1 |
0.6 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.1 |
0.2 |
GO:0042364 |
water-soluble vitamin biosynthetic process(GO:0042364) |
| 0.1 |
0.1 |
GO:0000479 |
endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
| 0.1 |
0.1 |
GO:0015959 |
diadenosine polyphosphate metabolic process(GO:0015959) |
| 0.1 |
0.5 |
GO:0045475 |
locomotor rhythm(GO:0045475) |
| 0.1 |
0.3 |
GO:0050884 |
neuromuscular process controlling posture(GO:0050884) |
| 0.1 |
1.0 |
GO:0070059 |
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
| 0.1 |
0.2 |
GO:0032493 |
response to bacterial lipoprotein(GO:0032493) |
| 0.1 |
0.3 |
GO:0001937 |
negative regulation of endothelial cell proliferation(GO:0001937) |
| 0.1 |
3.9 |
GO:0016579 |
protein deubiquitination(GO:0016579) |
| 0.1 |
0.6 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.1 |
0.3 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.1 |
0.2 |
GO:0006551 |
leucine metabolic process(GO:0006551) |
| 0.1 |
0.3 |
GO:1903779 |
regulation of cardiac conduction(GO:1903779) |
| 0.1 |
0.1 |
GO:0051542 |
elastin biosynthetic process(GO:0051542) |
| 0.1 |
0.1 |
GO:0018158 |
protein oxidation(GO:0018158) |
| 0.1 |
0.3 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.1 |
1.8 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.1 |
0.3 |
GO:1903146 |
regulation of mitophagy(GO:1903146) |
| 0.1 |
0.2 |
GO:0036265 |
RNA (guanine-N7)-methylation(GO:0036265) |
| 0.1 |
0.8 |
GO:0045806 |
negative regulation of endocytosis(GO:0045806) |
| 0.1 |
0.1 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.1 |
0.3 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.1 |
0.1 |
GO:0071895 |
odontoblast differentiation(GO:0071895) |
| 0.1 |
0.3 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.1 |
0.1 |
GO:0046292 |
formaldehyde metabolic process(GO:0046292) |
| 0.1 |
0.2 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 |
0.2 |
GO:0046381 |
CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.1 |
0.3 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.1 |
0.6 |
GO:0015936 |
coenzyme A metabolic process(GO:0015936) |
| 0.1 |
0.2 |
GO:2000211 |
regulation of glutamate metabolic process(GO:2000211) |
| 0.1 |
0.6 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.1 |
0.2 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.0 |
0.1 |
GO:0042447 |
hormone catabolic process(GO:0042447) |
| 0.0 |
0.1 |
GO:0034196 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.0 |
1.3 |
GO:0045773 |
positive regulation of axon extension(GO:0045773) |
| 0.0 |
0.2 |
GO:0032148 |
activation of protein kinase B activity(GO:0032148) |
| 0.0 |
0.0 |
GO:0060416 |
response to growth hormone(GO:0060416) |
| 0.0 |
0.4 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.0 |
0.0 |
GO:0003420 |
regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 0.0 |
0.1 |
GO:0090128 |
regulation of synapse maturation(GO:0090128) |
| 0.0 |
0.2 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.0 |
0.0 |
GO:0032066 |
nucleolus to nucleoplasm transport(GO:0032066) |
| 0.0 |
0.1 |
GO:0000469 |
cleavage involved in rRNA processing(GO:0000469) |
| 0.0 |
0.1 |
GO:0046416 |
D-amino acid metabolic process(GO:0046416) |
| 0.0 |
1.0 |
GO:0016601 |
Rac protein signal transduction(GO:0016601) |
| 0.0 |
0.2 |
GO:0003056 |
regulation of vascular smooth muscle contraction(GO:0003056) |
| 0.0 |
0.1 |
GO:0042297 |
vocal learning(GO:0042297) imitative learning(GO:0098596) observational learning(GO:0098597) learned vocalization behavior or vocal learning(GO:0098598) |
| 0.0 |
0.1 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.0 |
0.1 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.0 |
0.6 |
GO:0060218 |
hematopoietic stem cell differentiation(GO:0060218) |
| 0.0 |
0.2 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
| 0.0 |
0.2 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 0.0 |
0.0 |
GO:0010872 |
regulation of cholesterol esterification(GO:0010872) |
| 0.0 |
0.2 |
GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.0 |
0.2 |
GO:0050774 |
negative regulation of dendrite morphogenesis(GO:0050774) |
| 0.0 |
0.2 |
GO:1901385 |
regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.0 |
0.2 |
GO:1901724 |
positive regulation of cell proliferation involved in kidney development(GO:1901724) |
| 0.0 |
0.2 |
GO:0046668 |
programmed cell death involved in cell development(GO:0010623) retinal cell programmed cell death(GO:0046666) regulation of retinal cell programmed cell death(GO:0046668) |
| 0.0 |
0.1 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 0.0 |
0.0 |
GO:0048208 |
vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
| 0.0 |
0.2 |
GO:0071476 |
cellular hypotonic response(GO:0071476) |
| 0.0 |
0.2 |
GO:1902897 |
regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.0 |
0.7 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.0 |
2.0 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 0.0 |
1.8 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.0 |
0.5 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.0 |
0.5 |
GO:0061615 |
glycolytic process through fructose-6-phosphate(GO:0061615) |
| 0.0 |
0.3 |
GO:0001964 |
startle response(GO:0001964) |
| 0.0 |
0.0 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.0 |
0.0 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 0.0 |
0.2 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.0 |
0.1 |
GO:0034341 |
response to interferon-gamma(GO:0034341) |
| 0.0 |
0.3 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.0 |
0.0 |
GO:0060290 |
transdifferentiation(GO:0060290) |
| 0.0 |
0.0 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.0 |
0.1 |
GO:1900736 |
regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 0.0 |
0.2 |
GO:0033173 |
calcineurin-NFAT signaling cascade(GO:0033173) inositol phosphate-mediated signaling(GO:0048016) |
| 0.0 |
0.2 |
GO:0002082 |
regulation of oxidative phosphorylation(GO:0002082) |
| 0.0 |
0.3 |
GO:0009125 |
nucleoside monophosphate catabolic process(GO:0009125) |
| 0.0 |
0.4 |
GO:0051966 |
regulation of synaptic transmission, glutamatergic(GO:0051966) |
| 0.0 |
0.0 |
GO:0070366 |
regulation of hepatocyte differentiation(GO:0070366) |
| 0.0 |
0.2 |
GO:0070589 |
cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule metabolic process(GO:0044036) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) cell wall organization or biogenesis(GO:0071554) |
| 0.0 |
0.1 |
GO:0001991 |
regulation of systemic arterial blood pressure by circulatory renin-angiotensin(GO:0001991) |
| 0.0 |
0.1 |
GO:0060316 |
positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.0 |
0.2 |
GO:0046543 |
development of secondary female sexual characteristics(GO:0046543) |
| 0.0 |
1.0 |
GO:0035690 |
cellular response to drug(GO:0035690) |
| 0.0 |
0.1 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.0 |
0.7 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.0 |
0.0 |
GO:0090403 |
oxidative stress-induced premature senescence(GO:0090403) positive regulation of skeletal muscle cell differentiation(GO:2001016) |
| 0.0 |
0.6 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.0 |
1.3 |
GO:0019933 |
cAMP-mediated signaling(GO:0019933) |
| 0.0 |
0.0 |
GO:0034047 |
regulation of protein phosphatase type 2A activity(GO:0034047) |
| 0.0 |
0.6 |
GO:0032981 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.0 |
0.1 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.0 |
0.2 |
GO:2000489 |
hepatic stellate cell activation(GO:0035733) regulation of hepatic stellate cell activation(GO:2000489) |
| 0.0 |
0.8 |
GO:0042149 |
cellular response to glucose starvation(GO:0042149) |
| 0.0 |
0.3 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.0 |
1.0 |
GO:0047496 |
vesicle transport along microtubule(GO:0047496) |
| 0.0 |
0.2 |
GO:0070827 |
chromatin maintenance(GO:0070827) heterochromatin maintenance(GO:0070829) |
| 0.0 |
0.2 |
GO:0090308 |
regulation of methylation-dependent chromatin silencing(GO:0090308) |
| 0.0 |
0.1 |
GO:0060623 |
regulation of chromosome condensation(GO:0060623) |
| 0.0 |
0.1 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.0 |
0.2 |
GO:0035247 |
peptidyl-arginine omega-N-methylation(GO:0035247) |
| 0.0 |
0.0 |
GO:0002645 |
positive regulation of tolerance induction(GO:0002645) |
| 0.0 |
0.2 |
GO:0033108 |
mitochondrial respiratory chain complex assembly(GO:0033108) |
| 0.0 |
0.2 |
GO:0045003 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.0 |
0.2 |
GO:0048169 |
regulation of long-term neuronal synaptic plasticity(GO:0048169) |
| 0.0 |
0.1 |
GO:0031645 |
negative regulation of neurological system process(GO:0031645) |
| 0.0 |
0.1 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.0 |
0.2 |
GO:0046549 |
retinal cone cell development(GO:0046549) |
| 0.0 |
0.1 |
GO:0039532 |
negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
| 0.0 |
0.2 |
GO:0006451 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.0 |
1.5 |
GO:0032436 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
| 0.0 |
0.5 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.0 |
0.3 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.0 |
0.2 |
GO:0034312 |
diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 0.0 |
0.1 |
GO:0021540 |
corpus callosum morphogenesis(GO:0021540) |
| 0.0 |
0.4 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.0 |
0.1 |
GO:0048162 |
preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
| 0.0 |
0.3 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 0.0 |
0.2 |
GO:0071025 |
RNA surveillance(GO:0071025) |
| 0.0 |
0.2 |
GO:0006370 |
7-methylguanosine mRNA capping(GO:0006370) |
| 0.0 |
0.8 |
GO:0007212 |
dopamine receptor signaling pathway(GO:0007212) |
| 0.0 |
0.1 |
GO:0043987 |
histone H3-S10 phosphorylation(GO:0043987) |
| 0.0 |
0.1 |
GO:0060019 |
radial glial cell differentiation(GO:0060019) |
| 0.0 |
0.2 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.0 |
0.0 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.0 |
0.1 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 0.0 |
0.2 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
| 0.0 |
0.1 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.0 |
0.4 |
GO:0051057 |
positive regulation of small GTPase mediated signal transduction(GO:0051057) |
| 0.0 |
0.1 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.0 |
0.7 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.0 |
0.5 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.0 |
0.1 |
GO:2001012 |
mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
| 0.0 |
0.1 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.0 |
0.1 |
GO:0034969 |
histone arginine methylation(GO:0034969) |
| 0.0 |
0.1 |
GO:0030166 |
proteoglycan biosynthetic process(GO:0030166) |
| 0.0 |
0.6 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.0 |
0.0 |
GO:0000320 |
re-entry into mitotic cell cycle(GO:0000320) |
| 0.0 |
0.1 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.0 |
3.1 |
GO:0002230 |
positive regulation of defense response to virus by host(GO:0002230) |
| 0.0 |
0.0 |
GO:0014873 |
response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
| 0.0 |
0.2 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.0 |
0.7 |
GO:0045747 |
positive regulation of Notch signaling pathway(GO:0045747) |
| 0.0 |
0.1 |
GO:1901631 |
positive regulation of presynaptic membrane organization(GO:1901631) |
| 0.0 |
0.0 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) |
| 0.0 |
0.3 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.0 |
0.3 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.0 |
0.1 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.0 |
0.0 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 0.0 |
0.2 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.0 |
0.0 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.0 |
0.1 |
GO:0071786 |
endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.0 |
0.0 |
GO:2000823 |
regulation of androgen receptor activity(GO:2000823) |
| 0.0 |
0.2 |
GO:0015670 |
carbon dioxide transport(GO:0015670) |
| 0.0 |
0.0 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 0.0 |
0.1 |
GO:0035315 |
hair cell differentiation(GO:0035315) auditory receptor cell differentiation(GO:0042491) |
| 0.0 |
0.1 |
GO:1904526 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
| 0.0 |
0.2 |
GO:0031848 |
protection from non-homologous end joining at telomere(GO:0031848) |
| 0.0 |
0.1 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.0 |
0.2 |
GO:0021801 |
cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
| 0.0 |
0.0 |
GO:0090031 |
positive regulation of steroid hormone biosynthetic process(GO:0090031) |
| 0.0 |
0.4 |
GO:0097576 |
autophagosome maturation(GO:0097352) vacuole fusion(GO:0097576) |
| 0.0 |
0.2 |
GO:0001780 |
neutrophil homeostasis(GO:0001780) |
| 0.0 |
0.1 |
GO:0060462 |
lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
| 0.0 |
0.1 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.0 |
0.2 |
GO:0060059 |
embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.0 |
0.1 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.0 |
0.2 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.0 |
0.2 |
GO:0007614 |
short-term memory(GO:0007614) |
| 0.0 |
1.1 |
GO:0006888 |
ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.0 |
0.1 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.0 |
0.5 |
GO:0000002 |
mitochondrial genome maintenance(GO:0000002) |
| 0.0 |
0.1 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.0 |
0.3 |
GO:0061003 |
positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.0 |
0.1 |
GO:0008594 |
photoreceptor cell morphogenesis(GO:0008594) |
| 0.0 |
0.1 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.0 |
0.0 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.0 |
0.0 |
GO:0018065 |
protein-cofactor linkage(GO:0018065) |
| 0.0 |
0.1 |
GO:0018199 |
peptidyl-glutamine modification(GO:0018199) |
| 0.0 |
0.4 |
GO:0061098 |
positive regulation of protein tyrosine kinase activity(GO:0061098) |
| 0.0 |
0.1 |
GO:0021535 |
cell migration in hindbrain(GO:0021535) |
| 0.0 |
0.0 |
GO:0034382 |
chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 0.0 |
0.1 |
GO:2001224 |
positive regulation of neuron migration(GO:2001224) |
| 0.0 |
0.2 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.0 |
0.5 |
GO:2001240 |
negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
| 0.0 |
0.3 |
GO:0007530 |
sex determination(GO:0007530) |
| 0.0 |
0.4 |
GO:0015813 |
L-glutamate transport(GO:0015813) |
| 0.0 |
0.1 |
GO:0031022 |
nuclear migration along microfilament(GO:0031022) |
| 0.0 |
0.1 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.0 |
0.2 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.0 |
0.2 |
GO:0030049 |
muscle filament sliding(GO:0030049) |
| 0.0 |
0.4 |
GO:0070534 |
protein K63-linked ubiquitination(GO:0070534) |
| 0.0 |
0.2 |
GO:0043046 |
DNA methylation involved in gamete generation(GO:0043046) |
| 0.0 |
0.1 |
GO:0051661 |
maintenance of centrosome location(GO:0051661) |
| 0.0 |
0.1 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.0 |
0.1 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.0 |
0.2 |
GO:0051289 |
protein homotetramerization(GO:0051289) |
| 0.0 |
0.0 |
GO:1901740 |
negative regulation of myoblast fusion(GO:1901740) |
| 0.0 |
0.0 |
GO:0060314 |
regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.0 |
0.1 |
GO:0036314 |
response to sterol(GO:0036314) |
| 0.0 |
0.1 |
GO:0072395 |
signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
| 0.0 |
0.2 |
GO:0090200 |
positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.0 |
0.1 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 0.0 |
0.1 |
GO:0046697 |
decidualization(GO:0046697) |
| 0.0 |
0.2 |
GO:0006307 |
DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.0 |
0.0 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.0 |
0.0 |
GO:0002385 |
mucosal immune response(GO:0002385) |
| 0.0 |
0.1 |
GO:0045963 |
negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
| 0.0 |
0.1 |
GO:0033634 |
positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.0 |
0.7 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 |
0.1 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.0 |
0.2 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.0 |
0.3 |
GO:0060707 |
trophoblast giant cell differentiation(GO:0060707) |
| 0.0 |
0.4 |
GO:1902108 |
regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902108) |
| 0.0 |
0.1 |
GO:0018202 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
| 0.0 |
0.2 |
GO:0016558 |
protein import into peroxisome matrix(GO:0016558) |
| 0.0 |
0.2 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.0 |
0.5 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.0 |
0.1 |
GO:0070474 |
uterine smooth muscle contraction(GO:0070471) regulation of uterine smooth muscle contraction(GO:0070472) positive regulation of uterine smooth muscle contraction(GO:0070474) |
| 0.0 |
0.1 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.0 |
0.2 |
GO:0042048 |
olfactory behavior(GO:0042048) |
| 0.0 |
0.1 |
GO:0090502 |
RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.0 |
0.1 |
GO:0033566 |
gamma-tubulin complex localization(GO:0033566) |
| 0.0 |
0.1 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.0 |
1.5 |
GO:1903749 |
positive regulation of establishment of protein localization to mitochondrion(GO:1903749) positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.0 |
0.2 |
GO:0009083 |
branched-chain amino acid catabolic process(GO:0009083) |
| 0.0 |
0.4 |
GO:0008333 |
endosome to lysosome transport(GO:0008333) |
| 0.0 |
0.2 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.0 |
0.2 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.0 |
0.1 |
GO:1904729 |
regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal absorption(GO:1904478) regulation of intestinal lipid absorption(GO:1904729) |
| 0.0 |
0.1 |
GO:0000414 |
regulation of histone H3-K36 methylation(GO:0000414) |
| 0.0 |
0.0 |
GO:0035116 |
embryonic hindlimb morphogenesis(GO:0035116) |
| 0.0 |
0.2 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.0 |
0.0 |
GO:0010520 |
regulation of reciprocal meiotic recombination(GO:0010520) positive regulation of reciprocal meiotic recombination(GO:0010845) |
| 0.0 |
0.4 |
GO:0010761 |
fibroblast migration(GO:0010761) |
| 0.0 |
0.6 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.0 |
0.1 |
GO:0006449 |
regulation of translational termination(GO:0006449) |
| 0.0 |
0.0 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.0 |
0.0 |
GO:2000463 |
positive regulation of excitatory postsynaptic potential(GO:2000463) |
| 0.0 |
0.4 |
GO:0018196 |
peptidyl-asparagine modification(GO:0018196) |
| 0.0 |
0.1 |
GO:0050435 |
beta-amyloid metabolic process(GO:0050435) |
| 0.0 |
0.1 |
GO:0036010 |
protein localization to endosome(GO:0036010) |
| 0.0 |
0.1 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.0 |
0.1 |
GO:0035542 |
regulation of SNARE complex assembly(GO:0035542) |
| 0.0 |
0.9 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.0 |
0.2 |
GO:0034244 |
negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.0 |
0.0 |
GO:0036260 |
7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
| 0.0 |
0.1 |
GO:0006283 |
transcription-coupled nucleotide-excision repair(GO:0006283) |
| 0.0 |
0.0 |
GO:0021852 |
pyramidal neuron migration(GO:0021852) |
| 0.0 |
0.2 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.0 |
0.1 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.0 |
0.1 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.0 |
0.3 |
GO:0035067 |
negative regulation of histone acetylation(GO:0035067) |
| 0.0 |
0.1 |
GO:0007320 |
insemination(GO:0007320) |
| 0.0 |
0.3 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.0 |
0.1 |
GO:0031508 |
pericentric heterochromatin assembly(GO:0031508) |
| 0.0 |
0.4 |
GO:0002209 |
behavioral fear response(GO:0001662) behavioral defense response(GO:0002209) |
| 0.0 |
0.6 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.0 |
0.2 |
GO:0071229 |
cellular response to acid chemical(GO:0071229) |
| 0.0 |
0.1 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.0 |
0.1 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.0 |
0.3 |
GO:0048671 |
negative regulation of collateral sprouting(GO:0048671) |
| 0.0 |
0.4 |
GO:0086010 |
membrane depolarization during action potential(GO:0086010) |
| 0.0 |
0.0 |
GO:0051220 |
cytoplasmic sequestering of protein(GO:0051220) |
| 0.0 |
0.0 |
GO:0019852 |
L-ascorbic acid metabolic process(GO:0019852) |
| 0.0 |
0.1 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.0 |
0.6 |
GO:1902017 |
regulation of cilium assembly(GO:1902017) |
| 0.0 |
0.5 |
GO:0006720 |
isoprenoid metabolic process(GO:0006720) |
| 0.0 |
1.2 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
| 0.0 |
0.0 |
GO:0055089 |
fatty acid homeostasis(GO:0055089) |
| 0.0 |
0.2 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.0 |
0.1 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.0 |
0.2 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.0 |
0.0 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.0 |
0.1 |
GO:0021670 |
lateral ventricle development(GO:0021670) |
| 0.0 |
0.1 |
GO:0042347 |
negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.0 |
0.1 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 0.0 |
0.0 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.0 |
0.0 |
GO:0031639 |
plasminogen activation(GO:0031639) |
| 0.0 |
0.0 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) |
| 0.0 |
0.3 |
GO:0006900 |
membrane budding(GO:0006900) |
| 0.0 |
0.1 |
GO:1990034 |
calcium ion export from cell(GO:1990034) |
| 0.0 |
0.1 |
GO:0045404 |
positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
| 0.0 |
0.1 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
| 0.0 |
0.0 |
GO:0042420 |
dopamine catabolic process(GO:0042420) |
| 0.0 |
0.0 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.0 |
0.0 |
GO:0002701 |
negative regulation of production of molecular mediator of immune response(GO:0002701) |
| 0.0 |
0.2 |
GO:0034198 |
cellular response to amino acid starvation(GO:0034198) |
| 0.0 |
0.2 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.0 |
0.2 |
GO:2000651 |
positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.0 |
0.1 |
GO:0021562 |
vestibulocochlear nerve development(GO:0021562) |
| 0.0 |
0.1 |
GO:0035115 |
embryonic forelimb morphogenesis(GO:0035115) |
| 0.0 |
0.1 |
GO:2001197 |
regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.0 |
0.3 |
GO:0072599 |
establishment of protein localization to endoplasmic reticulum(GO:0072599) |
| 0.0 |
0.0 |
GO:0033578 |
protein glycosylation in Golgi(GO:0033578) |
| 0.0 |
0.0 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.0 |
0.2 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.0 |
0.0 |
GO:0030656 |
regulation of vitamin metabolic process(GO:0030656) |
| 0.0 |
0.2 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
| 0.0 |
0.1 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.0 |
0.1 |
GO:0006103 |
2-oxoglutarate metabolic process(GO:0006103) |
| 0.0 |
0.0 |
GO:2000623 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.0 |
0.0 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 0.0 |
0.1 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 0.0 |
0.1 |
GO:0060525 |
prostate glandular acinus development(GO:0060525) secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.0 |
0.0 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 0.0 |
0.0 |
GO:0070633 |
transepithelial transport(GO:0070633) |
| 0.0 |
0.4 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.0 |
0.1 |
GO:0045351 |
type I interferon biosynthetic process(GO:0045351) |
| 0.0 |
0.0 |
GO:0006688 |
glycosphingolipid biosynthetic process(GO:0006688) |
| 0.0 |
0.0 |
GO:0030202 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) heparin metabolic process(GO:0030202) |
| 0.0 |
0.1 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 0.0 |
0.4 |
GO:0006487 |
protein N-linked glycosylation(GO:0006487) |
| 0.0 |
0.0 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.0 |
0.1 |
GO:0046325 |
negative regulation of glucose import(GO:0046325) |
| 0.0 |
0.1 |
GO:0051084 |
'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
| 0.0 |
0.0 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.0 |
0.1 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
| 0.0 |
0.1 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.0 |
0.1 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.0 |
0.0 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.0 |
0.0 |
GO:0060179 |
male mating behavior(GO:0060179) |
| 0.0 |
0.0 |
GO:0007602 |
phototransduction(GO:0007602) |
| 0.0 |
0.1 |
GO:0002097 |
tRNA wobble base modification(GO:0002097) |
| 0.0 |
0.1 |
GO:0030262 |
cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
| 0.0 |
0.0 |
GO:0034183 |
negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) negative regulation of sister chromatid cohesion(GO:0045875) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
| 0.0 |
0.1 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.0 |
0.0 |
GO:0006680 |
glucosylceramide catabolic process(GO:0006680) |
| 0.0 |
0.2 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.0 |
0.0 |
GO:0009644 |
response to high light intensity(GO:0009644) |
| 0.0 |
0.0 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.0 |
0.1 |
GO:1903901 |
negative regulation of viral life cycle(GO:1903901) |
| 0.0 |
0.1 |
GO:0006046 |
N-acetylglucosamine catabolic process(GO:0006046) |
| 0.0 |
0.0 |
GO:1902914 |
regulation of protein polyubiquitination(GO:1902914) |
| 0.0 |
0.1 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.0 |
0.1 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.0 |
0.2 |
GO:0016126 |
sterol biosynthetic process(GO:0016126) |
| 0.0 |
0.0 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.0 |
0.0 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.0 |
0.0 |
GO:1901163 |
trophoblast cell migration(GO:0061450) regulation of trophoblast cell migration(GO:1901163) negative regulation of trophoblast cell migration(GO:1901164) |
| 0.0 |
0.0 |
GO:2000468 |
regulation of peroxidase activity(GO:2000468) |
| 0.0 |
0.0 |
GO:0014029 |
neural crest formation(GO:0014029) |
| 0.0 |
0.1 |
GO:0010507 |
negative regulation of autophagy(GO:0010507) |
